{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:57:22Z","timestamp":1775732242216,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12325-025-03485-0","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:11:01Z","timestamp":1770963061000},"page":"1582-1600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["X-Linked Retinitis Pigmentosa (XLRP): An Investigation of the Impact of XLRP on Health-Related Quality of Life of Carers in Great Britain"],"prefix":"10.1007","volume":"43","author":[{"given":"Nicholas S.","family":"Durno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom R.","family":"Denee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystallia","family":"Pantiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debdeep","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Pungor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salla P.","family":"Oinasmaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate R.","family":"Arkell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"3","key":"3485_CR1","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1167\/iovs.06-0971","volume":"48","author":"MA Sandberg","year":"2007","unstructured":"Sandberg MA, Rosner B, Weigel-DiFranco C, Dryja TP, Berson EL. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Investig Ophthalmol Vis Sci. 2007;48(3):1298\u2013304.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"3485_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/138920211795860107","volume":"12","author":"S Ferrari","year":"2011","unstructured":"Ferrari S, Di Iorio E, Barbaro V, Ponzin D, S. Sorrentino F, Parmeggiani F. Retinitis pigmentosa: genes and disease mechanisms. Curr Genom. 2011;12(4):238\u201349.","journal-title":"Curr Genom"},{"issue":"14","key":"3485_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1167\/iovs.61.14.36","volume":"61","author":"V Di Iorio","year":"2020","unstructured":"Di Iorio V, Karali M, Melillo P, et al. Spectrum of disease severity in patients with X-linked retinitis pigmentosa due to RPGR mutations. Investig Ophthalmol Vis Sci. 2020;61(14):36\u201336.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3485_CR4","doi-asserted-by":"publisher","first-page":"100898","DOI":"10.1016\/j.preteyeres.2020.100898","volume":"82","author":"SR De Silva","year":"2021","unstructured":"De Silva SR, Arno G, Robson AG, et al. The X-linked retinopathies: physiological insights, pathogenic mechanisms, phenotypic features and novel therapies. Prog Retin Eye Res. 2021;82:100898.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"3485_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/aos.14662","volume":"99","author":"M Zada","year":"2021","unstructured":"Zada M, Cornish EE, Fraser CL, Jamieson RV, Grigg JR. Natural history and clinical biomarkers of progression in X-linked retinitis pigmentosa: a systematic review. Acta Ophthalmol. 2021;99(5):499\u2013510.","journal-title":"Acta Ophthalmol"},{"key":"3485_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S297287","author":"M Chivers","year":"2021","unstructured":"Chivers M, Li N, Pan F, Wieffer H, Slowik R, Leartsakulpanitch J. The burden of X-linked retinitis pigmentosa on patients and society: a narrative literature review. Clinicoecon Outcomes Res. 2021. https:\/\/doi.org\/10.2147\/CEOR.S297287.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"1","key":"3485_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s13023-021-02145-0","volume":"16","author":"BL Lam","year":"2021","unstructured":"Lam BL, Leroy BP, Black G, Ong T, Yoon D, Trzupek K. Genetic testing and diagnosis of inherited retinal diseases. Orphanet J Rare Dis. 2021;16(1):514.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"3485_CR8","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1007\/s12325-024-02935-5","volume":"41","author":"K Pungor","year":"2024","unstructured":"Pungor K, Lee J, Denee T, et al. Impacts of X-linked retinitis pigmentosa and patient pathways in European countries: results from the cross-sectional EXPLORE XLRP-1 physician survey. Adv Ther. 2024;41(8):3378\u201395.","journal-title":"Adv Ther"},{"key":"3485_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03546-8","author":"F Parmeggiani","year":"2025","unstructured":"Parmeggiani F, Weber M, Bremond-Gignac D, et al. The burden of X-linked retinitis pigmentosa (XLRP) on patient experience and patient-reported outcomes (PROs): findings from the EXPLORE XLRP-2 study. Eye. 2025. https:\/\/doi.org\/10.1038\/s41433-024-03546-8.","journal-title":"Eye"},{"issue":"6","key":"3485_CR10","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1007\/s12325-025-03196-6","volume":"42","author":"M Weber","year":"2025","unstructured":"Weber M, Parmeggiani F, Bremond-Gignac D, et al. The impacts of caregiving for patients with X-linked retinitis pigmentosa (XLRP): findings from the EXPLORE XLRP-2 study. Adv Ther. 2025;42(6):2922\u201336.","journal-title":"Adv Ther"},{"issue":"2","key":"3485_CR11","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1093\/pubmed\/fdad264","volume":"46","author":"FA Del Castillo","year":"2024","unstructured":"Del Castillo FA. Valuing informal care and recognizing care as foundational. J Public Health. 2024;46(2):e344\u20135.","journal-title":"J Public Health"},{"key":"3485_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2147\/OPTH.S241928","volume":"14","author":"O Galvin","year":"2020","unstructured":"Galvin O, Chi G, Brady L, Hippert C, Del Valle Rubido M, Daly A. The impact of inherited retinal diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a cost-of-illness perspective. Clin Ophthalmol. 2020;14:707\u201319.","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"3485_CR13","doi-asserted-by":"publisher","first-page":"S486","DOI":"10.1016\/j.jval.2023.09.2630","volume":"26","author":"L Matza","year":"2023","unstructured":"Matza L, Li N, Stewart K, et al. PCR193\u00a0health state utilities associated with X-linked retinitis pigmentosa in the United Kingdom. Value Health. 2023;26(12):S486.","journal-title":"Value Health"},{"issue":"12","key":"3485_CR14","doi-asserted-by":"publisher","first-page":"S296","DOI":"10.1016\/j.jval.2023.09.1566","volume":"26","author":"T Denee","year":"2023","unstructured":"Denee T, Lee J, Fartaes A, Ampeh K, Pungor K. HSD14 X-linked retinitis pigmentosa impacts patients\u2019 independence, work status, and quality of life: insights from the cross-sectional Explore Xlrp-1.2 physician survey. Value Health. 2023;26(12):S296.","journal-title":"Value Health"},{"key":"3485_CR15","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/healthcare11070988","volume":"11","author":"K Watanabe","year":"2023","unstructured":"Watanabe K, Hiratsuka Y, Yamamoto S, Murakami A. Economic impacts and quality of life for caregivers of patients with retinitis pigmentosa: a cross-sectional Japanese study. Healthcare. 2023;11:988.","journal-title":"Healthcare"},{"issue":"13","key":"3485_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/09638288.2016.1193233","volume":"39","author":"K Mutch","year":"2017","unstructured":"Mutch K, Methley A, Hamid S, Moore P, Jacob A. If they are OK, we are OK: the experience of partners living with neuromyelitis optica. Disabil Rehabil. 2017;39(13):1279\u201386.","journal-title":"Disabil Rehabil"},{"key":"3485_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.rmed.2017.05.002","volume":"128","author":"J Cruz","year":"2017","unstructured":"Cruz J, Marques A, Machado A, O\u2019Hoski S, Goldstein R, Brooks D. Informal caregiving in COPD: a systematic review of instruments and their measurement properties. Respir Med. 2017;128:13\u201327.","journal-title":"Respir Med"},{"issue":"2","key":"3485_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s41669-021-00302-6","volume":"6","author":"SH Lo","year":"2022","unstructured":"Lo SH, Lloyd A, Elkhalifa S, Sisic Z, van Nooten FE. Time trade-off utilities for hereditary angioedema health and caregiver states. PharmacoEcon Open. 2022;6(2):231\u20139.","journal-title":"PharmacoEcon Open"},{"issue":"4","key":"3485_CR19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s11136-022-03253-5","volume":"32","author":"PG Bal\u00e1zs","year":"2023","unstructured":"Bal\u00e1zs PG, Erd\u0151si D, Zempl\u00e9nyi A, Brodszky V. Time trade-off health state utility values for depression: a systematic review and meta-analysis. Qual Life Res. 2023;32(4):923\u201337.","journal-title":"Qual Life Res"},{"issue":"1","key":"3485_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.36469\/jheor.2023.71344","volume":"10","author":"D Hughes","year":"2023","unstructured":"Hughes D, Lenny A, Shah K, Longworth L, Devercelli G, Ayodele O. Estimation of health state utility values in Fabry disease using vignette development and valuation. J Health Econ Outcomes Res. 2023;10(1):80.","journal-title":"J Health Econ Outcomes Res"},{"issue":"5","key":"3485_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1017\/S0266462320000665","volume":"36","author":"M Meregaglia","year":"2020","unstructured":"Meregaglia M, Nicod E, Drummond M. The estimation of health state utility values in rare diseases: overview of existing techniques. Int J Technol Assess Health Care. 2020;36(5):469\u201373.","journal-title":"Int J Technol Assess Health Care"},{"key":"3485_CR22","unstructured":"National Institute for Health and Care Excellence (NICE). NICE health technology evaluations: the manual. 2022. https:\/\/www.nice.org.uk\/guidance\/GID-NGC10018\/documents\/642. Accessed 12 Jan 2026."},{"issue":"7","key":"3485_CR23","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s11136-022-03101-6","volume":"31","author":"D Dawoud","year":"2022","unstructured":"Dawoud D, Lamb A, Moore A, et al. Capturing what matters: updating NICE methods guidance on measuring and valuing health. Qual Life Res. 2022;31(7):2167\u201373.","journal-title":"Qual Life Res"},{"key":"3485_CR24","doi-asserted-by":"publisher","first-page":"S705","DOI":"10.1016\/j.jval.2020.08.1825","volume":"23","author":"C Bregman","year":"2020","unstructured":"Bregman C, Dawoud D, Dent R. PRO89 the use of EQ-5D in NICE highly specialised technologies evaluations: a review of published guidance. Value Health. 2020;23:S705.","journal-title":"Value Health"},{"key":"3485_CR25","unstructured":"National Institute for Health and Care Excellence (NICE): CHTE methods review: health-related quality of life Task and finish group report. 2020. https:\/\/rees-france.com\/wp-content\/uploads\/2020\/12\/2020-CHTE-2020-Health-related-quality-of-life-.pdf. Accessed 12 Jan 2026."},{"key":"3485_CR26","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/08901171211030142f","volume":"35","author":"MP Martin","year":"2021","unstructured":"Martin MP, McEntee ML, Suri Y. Caregiver quality of life: how to measure it and why. Am J Health Promot. 2021;35:1042\u20135.","journal-title":"Am J Health Promot"},{"issue":"10","key":"3485_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.11622\/smedj.2021033","volume":"63","author":"YX Loo","year":"2022","unstructured":"Loo YX, Yan S, Low LL. Caregiver burden and its prevalence, measurement scales, predictive factors and impact: a review with an Asian perspective. Singap Med J. 2022;63(10):593\u2013603.","journal-title":"Singap Med J"},{"issue":"2","key":"3485_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/psyg.12087","volume":"15","author":"GR de Oliveira","year":"2015","unstructured":"de Oliveira GR, Neto JF, de Camargo SM, Lucchetti ALG, Espinha DCM, Lucchetti G. Caregiving across the lifespan: comparing caregiver burden, mental health, and quality of life. Psychogeriatrics. 2015;15(2):123\u201332.","journal-title":"Psychogeriatrics"},{"issue":"1","key":"3485_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2318-14-23","volume":"14","author":"E Graessel","year":"2014","unstructured":"Graessel E, Berth H, Lichte T, Grau H. Subjective caregiver burden: validity of the 10-item short version of the Burden Scale for Family Caregivers BSFC-s. BMC Geriatr. 2014;14(1):23.","journal-title":"BMC Geriatr"},{"issue":"3","key":"3485_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ymgme.2013.07.020","volume":"110","author":"TA Kanters","year":"2013","unstructured":"Kanters TA, van der Ploeg AT, Brouwer WB, Hakkaart L. The impact of informal care for patients with Pompe disease: an application of the CarerQol instrument. Mol Genet Metab. 2013;110(3):281\u20136.","journal-title":"Mol Genet Metab"},{"issue":"Supplement_1","key":"3485_CR31","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1093\/geronb\/gbac031","volume":"77","author":"IW Kolodziej","year":"2022","unstructured":"Kolodziej IW, Coe NB, Van Houtven CH. The impact of care intensity and work on the mental health of family caregivers: losses and gains. J Gerontol Ser B. 2022;77(Supplement_1):S98\u2013111.","journal-title":"J Gerontol Ser B"},{"key":"3485_CR32","doi-asserted-by":"publisher","first-page":"104443","DOI":"10.1016\/j.ridd.2023.104443","volume":"135","author":"H Oliver","year":"2023","unstructured":"Oliver H, Seccurro D, Dorich J, Rice M, Schwartz T, Harpster K. \u201cEven though a lot of kids have it, not a lot of people have knowledge of it\u201d: a qualitative study exploring the perspectives of parents of children with cerebral\/cortical visual impairment. Res Dev Disabil. 2023;135:104443.","journal-title":"Res Dev Disabil"},{"issue":"2","key":"3485_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10995-008-0434-1","volume":"14","author":"K Kuhlthau","year":"2010","unstructured":"Kuhlthau K, Kahn R, Hill KS, Gnanasekaran S, Ettner SL. The well-being of parental caregivers of children with activity limitations. Matern Child Health J. 2010;14(2):155\u201363.","journal-title":"Matern Child Health J"},{"key":"3485_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-025-01761-y","author":"LS Matza","year":"2025","unstructured":"Matza LS, Li N, Stewart KD, et al. Health state utilities associated with X-linked retinitis pigmentosa (XLRP). Eur J Health Econ. 2025. https:\/\/doi.org\/10.1007\/s10198-025-01761-y.","journal-title":"Eur J Health Econ"},{"key":"3485_CR35","doi-asserted-by":"crossref","unstructured":"Stolk E, Ramos-Go\u00f1i JM, Ludwig K, Oppe M, Norman R. The development and strengthening of methods for valuing EQ-5D-5L\u2014an overview. Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide 2022:13\u201327.","DOI":"10.1007\/978-3-030-89289-0_2"},{"key":"3485_CR36","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40273-016-0404-1","volume":"34","author":"M Oppe","year":"2016","unstructured":"Oppe M, Rand-Hendriksen K, Shah K, Ramos-Go\u00f1i JM, Luo N. EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34:993\u20131004.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"3485_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/0272989X9401400102","volume":"14","author":"DL Patrick","year":"1994","unstructured":"Patrick DL, Starks HE, Cain KC, Uhlmann RF, Pearlman RA. Measuring preferences for health states worse than death. Med Decis Mak. 1994;14(1):9\u201318.","journal-title":"Med Decis Mak"},{"issue":"3","key":"3485_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/01.mlr.0000252166.76255.68","volume":"45","author":"LM Lamers","year":"2007","unstructured":"Lamers LM. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets. Med Care. 2007;45(3):238\u201344.","journal-title":"Med Care"},{"key":"3485_CR39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2165\/00019053-200826090-00007","volume":"26","author":"J Brazier","year":"2008","unstructured":"Brazier J. Valuing health states for use in cost-effectiveness analysis. Pharmacoeconomics. 2008;26:769\u201379.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"3485_CR40","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jval.2011.01.004","volume":"14","author":"D Rowen","year":"2011","unstructured":"Rowen D, Brazier J, Young T, et al. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health. 2011;14(5):721\u201331.","journal-title":"Value Health"},{"issue":"9","key":"3485_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18090","volume":"18","author":"L Longworth","year":"2014","unstructured":"Longworth L, Yang Y, Young T, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9):1.","journal-title":"Health Technol Assess"},{"key":"3485_CR42","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s40273-015-0295-6","volume":"33","author":"N Payakachat","year":"2015","unstructured":"Payakachat N, Ali MM, Tilford JM. Can the EQ-5D detect meaningful change? A systematic review. Pharmacoeconomics. 2015;33:1137\u201354.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"3485_CR43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jval.2011.08.002","volume":"15","author":"J Tosh","year":"2012","unstructured":"Tosh J, Brazier J, Evans P, Longworth L. A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health. 2012;15(1):118\u201327.","journal-title":"Value Health"},{"key":"3485_CR44","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s11136-013-0412-y","volume":"22","author":"RK Naik","year":"2013","unstructured":"Naik RK, Gries KS, Rentz AM, Kowalski JW, Revicki DA. Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis. Qual Life Res. 2013;22:2801\u20138.","journal-title":"Qual Life Res"},{"issue":"10","key":"3485_CR45","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s11136-024-03737-6","volume":"33","author":"V Sokolova","year":"2024","unstructured":"Sokolova V, Faller J, Asfia SKBM, Engel L. Assessing the psychometric performance of the EQ-5D-5L among informal caregivers of people with dementia. Qual Life Res. 2024;33(10):2693\u2013704.","journal-title":"Qual Life Res"},{"key":"3485_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-017-0591-2","volume":"15","author":"C Reed","year":"2017","unstructured":"Reed C, Barrett A, Lebrec J, et al. How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer\u2019s disease? Health Qual Life Outcomes. 2017;15:1\u20139.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"3485_CR47","doi-asserted-by":"publisher","first-page":"FNL58","DOI":"10.2217\/fnl-2022-0004","volume":"17","author":"S Acaster","year":"2022","unstructured":"Acaster S, Williams K, Skrobanski H, Buesch K. Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency. Future Neurol. 2022;17(2):FNL58.","journal-title":"Future Neurol"},{"issue":"5","key":"3485_CR48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1524-4733.2009.00527.x","volume":"12","author":"C Czoski-Murray","year":"2009","unstructured":"Czoski-Murray C, Carlton J, Brazier J, Young T, Papo NL, Kang HK. Valuing condition-specific health states using simulation contact lenses. Value Health. 2009;12(5):793\u20139.","journal-title":"Value Health"},{"key":"3485_CR49","unstructured":"Office for National Statistics, Census 2021. https:\/\/www.ons.gov.uk. Accessed 12 Jan 2026."},{"key":"3485_CR50","unstructured":"Scotland\u2019s Census, 2021. https:\/\/www.scotlandscensus.gov.uk\/. Accessed 12 Jan 2026."},{"issue":"1","key":"3485_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/INF.0b013e3181b41506","volume":"29","author":"M Brisson","year":"2010","unstructured":"Brisson M, S\u00e9n\u00e9cal M, Drolet M, Mansi JA. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. Pediatr Infect Dis J. 2010;29(1):73\u20135.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"3485_CR52","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s10826-009-9260-3","volume":"18","author":"SD Grosse","year":"2009","unstructured":"Grosse SD, Flores AL, Ouyang L, Robbins JM, Tilford JM. Impact of spina bifida on parental caregivers: findings from a survey of Arkansas families. J Child Fam Stud. 2009;18(5):574\u201381.","journal-title":"J Child Fam Stud"},{"issue":"2","key":"3485_CR53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/WAD.0000000000000558","volume":"37","author":"VJ van Hezik-Wester","year":"2023","unstructured":"van Hezik-Wester VJ, Handels RL, Wolfs CA, Kanters TA. Caregiver burden and quality of life across Alzheimer\u2019s disease severity stages. Alzheimer Dis Assoc Disord. 2023;37(2):134\u201341.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"3485_CR54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7224\/1537-2073-14.4.179","volume":"14","author":"S Gupta","year":"2012","unstructured":"Gupta S, Goren A, Phillips AL, Stewart M. Self-reported burden among caregivers of patients with multiple sclerosis. Int J MS Care. 2012;14(4):179\u201387.","journal-title":"Int J MS Care"},{"issue":"2","key":"3485_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/14737167.2018.1386561","volume":"18","author":"O Rochanathimoke","year":"2018","unstructured":"Rochanathimoke O, Riewpaiboon A, Postma MJ, Thinyounyong W, Thavorncharoensap M. Health related quality of life impact from rotavirus diarrhea on children and their family caregivers in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2018;18(2):215\u201322.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"3485_CR56","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12888-015-0547-1","volume":"15","author":"S Gupta","year":"2015","unstructured":"Gupta S, Isherwood G, Jones K, Van Impe K. Assessing health status in informal schizophrenia caregivers compared with health status in non-caregivers and caregivers of other conditions. BMC Psychiatry. 2015;15(1):162.","journal-title":"BMC Psychiatry"},{"issue":"5","key":"3485_CR57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0895-4356(88)90049-2","volume":"41","author":"EA Mohide","year":"1988","unstructured":"Mohide EA, Torrance GW, Streiner DL, Pringle DM, Gilbert R. Measuring the wellbeing of family caregivers using the time trade-off technique. J Clin Epidemiol. 1988;41(5):475\u201382.","journal-title":"J Clin Epidemiol"},{"key":"3485_CR58","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.pedn.2025.02.007","volume":"81","author":"ZH Chirani","year":"2025","unstructured":"Chirani ZH, Pouralizadeh M, Yaghobi Y, Leili EK. Relationship of caregiving burden and adaptive behaviors in mothers of children with chronic diseases. J Pediatr Nurs. 2025;81:e113\u201320.","journal-title":"J Pediatr Nurs"},{"key":"3485_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40359-021-00556-z","volume":"9","author":"A Kazemi","year":"2021","unstructured":"Kazemi A, Azimian J, Mafi M, Allen K-A, Motalebi SA. Caregiver burden and coping strategies in caregivers of older patients with stroke. BMC Psychol. 2021;9:1\u20139.","journal-title":"BMC Psychol"},{"key":"3485_CR60","unstructured":"Retina UK: Sight loss survey; 2019. https:\/\/retinauk.org.uk\/wp-content\/uploads\/2021\/06\/Retina-UK-sight-loss-survey-report-SelfComms-FINAL.pdf. Accessed 12 Jan 2026."},{"issue":"1","key":"3485_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jval.2015.10.012","volume":"19","author":"K Shah","year":"2016","unstructured":"Shah K, Mulhern B, Longworth L, Janssen MFB. An empirical study of two alternative comparators for use in time trade-off studies. Value Health. 2016;19(1):53\u20139.","journal-title":"Value Health"},{"key":"3485_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2165\/00019053-200017020-00004","volume":"17","author":"C Green","year":"2000","unstructured":"Green C, Brazier J, Deverill M. Valuing health-related quality of life: a review of health state valuation techniques. Pharmacoeconomics. 2000;17:151\u201365.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"3485_CR63","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/0272989X14524989","volume":"34","author":"Y Edelaar-Peeters","year":"2014","unstructured":"Edelaar-Peeters Y, Stiggelbout AM, Van Den Hout WB. Qualitative and quantitative analysis of interviewer help answering the time tradeoff. Med Decis Mak. 2014;34(5):655\u201365.","journal-title":"Med Decis Mak"},{"issue":"4","key":"3485_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14737167.2020.1779062","volume":"20","author":"AK Lugn\u00e9r","year":"2020","unstructured":"Lugn\u00e9r AK, Krabbe PF. An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health. Expert Rev Pharmacoecon Outcomes Res. 2020;20(4):331\u201342.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"}],"updated-by":[{"DOI":"10.1007\/s12325-026-03547-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03485-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03485-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03485-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:02:28Z","timestamp":1775728948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03485-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3485"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03485-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12325-026-03547-x","URL":"https:\/\/doi.org\/10.1007\/s12325-026-03547-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nicholas Durno, Krystallia Pantiri and Debdeep Chattopadhyay are employees of OPEN Health. Kate Arkell is an employee of Retina UK and provided advice during the study. Katalin Pungor, Tom Denee and Salla Oinasmaa are present employees and hold stock, or options, as part of a balanced investment portfolio. Khalid Siddiqui was an employee of Johnson & Johnson during the time that the study was conducted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study received ethical approval and exempt status from Pearl IRB in the USA (IRB reference 2024-0301). The study was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments. Participants provided informed consent to data collection and publication of aggregate results by signing the informed consent form that was reviewed and approved by Pearl IRB before collection of data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}